Results
|
|
521.
|
|
|
|
522.
|
Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3. [electronic resource] by
- George, Prince
- Bali, Purva
- Annavarapu, Srinivas
- Scuto, Anna
- Fiskus, Warren
- Guo, Fei
- Sigua, Celia
- Sondarva, Gautam
- Moscinski, Lynn
- Atadja, Peter
- Bhalla, Kapil
Producer: 20050303
In:
Blood vol. 105
Availability: No items available.
|
|
|
523.
|
|
|
|
524.
|
Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells. [electronic resource] by
- Lin, Zhaohu
- Zhang, Zhuqing
- Jiang, Xiaoxiao
- Kou, Xinhui
- Bao, Yong
- Liu, Huijuan
- Sun, Fanghui
- Ling, Shuang
- Qin, Ning
- Jiang, Lan
- Yang, Yonghua
Producer: 20170907
In:
Oncotarget vol. 8
Availability: No items available.
|
|
|
525.
|
Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia. [electronic resource] by
- Vilas-Zornoza, A
- Agirre, X
- Abizanda, G
- Moreno, C
- Segura, V
- De Martino Rodriguez, A
- José-Eneriz, E S
- Miranda, E
- Martín-Subero, J I
- Garate, L
- Blanco-Prieto, M J
- García de Jalón, J A
- Rio, P
- Rifón, J
- Cigudosa, J C
- Martinez-Climent, J A
- Román-Gómez, J
- Calasanz, M J
- Ribera, J M
- Prósper, F
Producer: 20121009
In:
Leukemia vol. 26
Availability: No items available.
|
|
|
526.
|
|
|
|
527.
|
Superior efficacy of a combined epigenetic therapy against human mantle cell lymphoma cells. [electronic resource] by
- Fiskus, Warren
- Rao, Rekha
- Balusu, Ramesh
- Ganguly, Siddhartha
- Tao, Jianguo
- Sotomayor, Eduardo
- Mudunuru, Uma
- Smith, Jacqueline E
- Hembruff, Stacey L
- Atadja, Peter
- Marquez, Victor E
- Bhalla, Kapil
Producer: 20130426
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 18
Availability: No items available.
|
|
|
528.
|
Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells. [electronic resource] by
- Fiskus, Warren
- Sharma, Sunil
- Qi, Jun
- Valenta, John A
- Schaub, Leasha J
- Shah, Bhavin
- Peth, Karissa
- Portier, Bryce P
- Rodriguez, Melissa
- Devaraj, Santhana G T
- Zhan, Ming
- Sheng, Jianting
- Iyer, Swaminathan P
- Bradner, James E
- Bhalla, Kapil N
Producer: 20150102
In:
Molecular cancer therapeutics vol. 13
Availability: No items available.
|
|
|
529.
|
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma. [electronic resource] by
- Nagaraja, Surya
- Vitanza, Nicholas A
- Woo, Pamelyn J
- Taylor, Kathryn R
- Liu, Fang
- Zhang, Lei
- Li, Meng
- Meng, Wei
- Ponnuswami, Anitha
- Sun, Wenchao
- Ma, Jie
- Hulleman, Esther
- Swigut, Tomek
- Wysocka, Joanna
- Tang, Yujie
- Monje, Michelle
Producer: 20170821
In:
Cancer cell vol. 31
Availability: No items available.
|
|
|
530.
|
Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial. [electronic resource] by
- San-Miguel, Jesús F
- Hungria, Vania T M
- Yoon, Sung-Soo
- Beksac, Meral
- Dimopoulos, Meletios A
- Elghandour, Ashraf
- Jedrzejczak, Wieslaw W
- Günther, Andreas
- Nakorn, Thanyaphong N
- Siritanaratkul, Noppadol
- Schlossman, Robert L
- Hou, Jian
- Moreau, Philippe
- Lonial, Sagar
- Lee, Jae H
- Einsele, Hermann
- Sopala, Monika
- Bengoudifa, Bourras-Rezki
- Binlich, Florence
- Richardson, Paul G
Producer: 20180104
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|